Insulin Pens Market Size by Segments, Share, Regulatory, Reimbursement and Forecast to 2033, Featuring Novo Nordisk, Eli Lilly and Sanofi
14 févr. 2024 11h59 HE
|
Research and Markets
Dublin, Feb. 14, 2024 (GLOBE NEWSWIRE) -- The "Insulin Pens Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033" report has been added to ResearchAndMarkets.com's...
North America Sulfonylureas Market Projected to Grow, Hitting USD 3.35 Billion Valuation by 2028 with Notable CAGR of 1.90%
30 janv. 2024 20h00 HE
|
Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "North America Sulfonylureas Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)" report has been added to ...
Europe Insulin Pens Market Projected to Reach USD 2.29 Billion by 2028 - Technological Innovations and Rising Diabetes Prevalence Fueling Growth
30 janv. 2024 19h58 HE
|
Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "Europe Insulin Pens Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)" report has been added to ResearchAndMarkets.com's...
RYZODEG Drug & Market Forecast Report 2023-2032: Reveals Comprehensive Insights for Type 1 Diabetes Mellitus Treatment - Mechanism of Action, Clinical Assessments, Market Dynamics, Emerging Competitors
30 janv. 2024 06h58 HE
|
Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "RYZODEG Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. Offering an in-depth analysis of the...
Cell Therapies for Type 1 Diabetes: 2023-2030 Industry Outlook Featuring Analysis of Leading Players Novo Nordisk, Sanofi, Vertex Pharmaceuticals, Sernova, and Throne Biotechnologies
30 janv. 2024 04h49 HE
|
Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "Cell Therapies for Type 1 Diabetes (2023 Edition): Global and Country Analysis By Epidemiology, Pipeline and Target Market Assessment" report has been...
Global Insulin Delivery Pen Market Forecast Shows Strong Growth up to 2032 with Technological Advancements and Rising Diabetes Prevalence
30 janv. 2024 03h40 HE
|
Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "Global Insulin Delivery Pen Market Size, Growth, Trends, Share and Forecast 2024 - 2032" report has been added to ResearchAndMarkets.com's offering. ...
Insulin Delivery Devices Market: Surge in Global Diabetes Prevalence Catalyzing Robust Growth to 2031
29 janv. 2024 12h35 HE
|
Research and Markets
Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "Insulin Delivery Device Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application,...
Biosimilar Insulin Market Global Industry Analysis - Market Set to Surge, Spearheaded by High Demand in APAC and Cost-Effective Innovations
29 janv. 2024 12h24 HE
|
Research and Markets
Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "Biosimilar Insulin Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application,...
PRV-031 (teplizumab) Drug Insight and Market Forecast to 2032: Highlights Opportunities Across Key Regions
29 janv. 2024 12h21 HE
|
Research and Markets
Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "PRV-031 Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. This report reveals extensive insights...
Insulin Delivery Pipeline Clinical Research Report 2023: Analysis of Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies
24 janv. 2024 15h16 HE
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Insulin Delivery Pipeline Report Including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update"...